NCT07298200 — Jia Wei neoantigen vaccine trial
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
Registry record
| Registry ID | NCT07298200 ↗ |
|---|---|
| Lead sponsor | Jia Wei |
| Collaborators | NeoCura |
| Phase | Phase 1 |
| Status | Recruiting |
| Indication | Advanced Gastric Cancer |
| Enrollment | 18 participants (target) |
| Start date | 2025-12-26 |
| Primary completion | 2028-06 (est.) |
| Last registry update | 25 Feb 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT07298200), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT07298200?
NCT07298200 (Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer) is registered on ClinicalTrials.gov as Phase 1, sponsored by Jia Wei.
Is NCT07298200 recruiting?
As of the 2026-02-25 registry update, NCT07298200 is listed as "Recruiting". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT07298200?
The lead sponsor is Jia Wei. Collaborators: NeoCura.
What condition does NCT07298200 study?
The registered condition is Advanced Gastric Cancer. Primary completion is listed as 2028-06 (estimated).
Are results available for NCT07298200?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT07298200.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.